Rosalind Advisors’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,123
Closed -$168K 39
2024
Q3
$168K Hold
10,123
0.11% 27
2024
Q2
$194K Buy
+10,123
New +$194K 0.15% 33